Study of some invasiveness markers as pathogenic factors in oral pseudoepitheliomatous hyperplasia.
Pseudoepitheliomatous hyperplasia is a benign reactivated epithelial lesion secondary to another pathology, whose incidence is difficult to establish. There still exist controversies regarding the origin and pathogenesis of these lesions. For this purpose, we performed an immuno-histochemical study upon 20 cases of oral pseudoepitheliomatous hyperplasia associated with inflammatory and neoplastic conditions, investigating a series of markers with a possible pathogenic potential in developing this type of lesions. Thus, the immunoreactivity study for β-catenin showed the presence of a membrane reactivity in all the stratum spinosum and a predominantly cytoplasmatic reactivity, more rarely a nuclear one, in the cells of the basal stratum cells, especially in the epithelial apices that descend deeply in the chorion. Instead, in the case of vimentin, the reactivity was present only in the epithelial apices, especially in the peripheral cells, in comparison to the central ones, and especially in the cases where the epithelial apices descended deeply in the sublesional chorion. Moreover, we observed that the MMP9 reactivity in pseudoepitheliomatous hyperplasia lesions was present in the cells at the epithelium-chorion interface and especially in the epithelial apices that descend deeply into the chorion, and also in the epithelial chorion and networks. The study for CXCR4 immuno-reactivity showed a good reactivity in almost all layers of this hyperplastic lesion, with a maximum reactivity especially inside the epithelial apices that descend deeply in the sublesional chorion. Such an immunoprofile suggests the ability of the oral epithelial cells to undergo an epithelial mesenchymal transition process, thus acquiring mesenchymal characteristics through which it deeply migrates in the subadjacent chorion and contributes to the formation of epithelial apices in pseudoepitheliomatous hyperplasia. Moreover, the invasive ability of these lesions is also given by the average quantity of matrix metalloproteinases present in the epithelium-chorion interface determined by the activation of CXCR4 receptors at this level.
Department of Pathology, Faculty of Dental Medicine, University of Medicine and Pharmacy of Craiova, Romania; c_margaritescu2000@yahoo.com.
Roxana Maria
RM
Pascu
Claudiu
C
Mărgăritescu
Monica Mihaela
MM
CrăiŢoiu
Alma Maria
AM
Florescu
Ileana Cristiana
IC
Croitoru
Adelina Gabriela
AG
Bobic
Ciprian LaurenŢiu
CL
Pătru
Gheorghe Dan
GD
Mălăescu
Ştefania
Ş
CrăiŢoiu
D014408:Biomarkers, Tumor / Q000378:metabolism*; D005260:Female; D005881:Gingiva / Q000378:metabolism / Q000473:pathology; D006801:Humans; D006965:Hyperplasia; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D008875:Middle Aged; D009055:Mouth / Q000473:pathology*; D009062:Mouth Neoplasms / Q000378:metabolism* / Q000473:pathology*; D009092:Mucous Membrane / Q000473:pathology; D009361:Neoplasm Invasiveness; D019718:Receptors, CXCR4 / Q000378:metabolism; D014746:Vimentin / Q000378:metabolism; D051176:beta Catenin / Q000378:metabolism
D014408:Biomarkers, Tumor; C527276:CXCR4 protein, human; D019718:Receptors, CXCR4; D014746:Vimentin; D051176:beta Catenin; D020780:Matrix Metalloproteinase 9